Steven Wayne Goldstein
Pfizer
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Steven Wayne Goldstein.
Bioorganic & Medicinal Chemistry Letters | 2009
Mohamed M. A. Awad; Marc Bazin; Frederic Feru; Steven Wayne Goldstein; Cyrille Kuhn
A series of tetrahydroquinoline-derived inhibitors of the CRTH2 receptor was discovered by a high throughput screen. Optimization of these compounds for potency and pharmacokinetic properties led to the discovery of potent and orally bioavailable CRTH2 antagonists.
Bioorganic & Medicinal Chemistry Letters | 1992
Judith L. Collins; Paul J. Dambek; Steven Wayne Goldstein; W. Stephen Faraci
Abstract CP-99,711, identified in a screening program, displaces [125I]-glucagon from its rat liver receptor. We describe here the synthesis of this compound and its characterization as a functional glucagon receptor antagonist.
Journal of Medicinal Chemistry | 2012
Ivan Viktorovich Efremov; Felix Vajdos; Kris A. Borzilleri; Steven Capetta; Hou Chen; Peter Hans Dorff; Jason K. Dutra; Steven Wayne Goldstein; Mahmoud N. Mansour; Alexander S. McColl; Stephen Noell; Christine E. Oborski; Thomas N. O’Connell; Theresa J. O’Sullivan; Jayvardhan Pandit; Hong Wang; BinQing Wei; Jane M. Withka
The aspartyl protease β-secretase, or BACE, has been demonstrated to be a key factor in the proteolytic formation of Aβ-peptide, a major component of plaques in the brains of Alzheimers disease (AD) patients, and inhibition of this enzyme has emerged as a major strategy for pharmacologic intervention in AD. An X-ray-based fragment screen of Pfizers proprietary fragment collection has resulted in the identification of a novel BACE binder featuring spiropyrrolidine framework. Although exhibiting only weak inhibitory activity against the BACE enzyme, the small compound was verified by biophysical and NMR-based methods as a bona fide BACE inhibitor. Subsequent optimization of the lead compound, relying heavily on structure-based drug design and computational prediction of physiochemical properties, resulted in a nearly 1000-fold improvement in potency while maintaining ligand efficiency and properties predictive of good permeability and low P-gp liability.
Tetrahedron Letters | 1998
Peter Hans Dorff; Gordon Chiu; Steven Wayne Goldstein; Bradley Paul Morgan
Abstract A procedure for preparing novel phosphinopeptoids, 1 , on a solid support is described. The key step in the synthesis includes a conjugate addition of the trivalent form of a protected aminomethylphosphinic acid ( 5 ) to a resin-bound acrylate.
Tetrahedron Letters | 1991
Steven Wayne Goldstein; Ruth E. McDermott; Michael Raymond Groton Makowski; Cynthia Eller
Abstract 2-Aminobenzophenones and acetophenones were N-acylated with α-azido carboxylic acids to give the corresponding anilides. Reductive cyclization provided 3-substituted-2H-1,4-benzodiazepin-2-ones in good (46–99%) yields.
Archive | 1991
Robert L. Dow; Steven Wayne Goldstein
Archive | 1989
David Alan Clark; Steven Wayne Goldstein; Gerald F. Holland; Bernard Hulin; James P. Rizzi
Archive | 1989
David Alan Clark; Bernard Hulin; Steven Wayne Goldstein
Journal of Medicinal Chemistry | 1992
Bernard Hulin; David Alan Clark; Steven Wayne Goldstein; Ruth E. McDermott; Paul J. Dambek; Werner H. Kappeler; Charles H. Lamphere; Diana M. Lewis; James P. Rizzi
Journal of Medicinal Chemistry | 1991
David Alan Clark; Steven Wayne Goldstein; Robert A. Volkmann; James Frederick Eggler; Gerald F. Holland; Bernard Hulin; Ralph W. Stevenson; Kreutter Dk; Gibbs Em; Krupp Mn